MENU
+Compare
GDOC
ETF ticker: NYSE ARCA
AS OF
Jul 21, 02:51 PM (EDT)
Price
$30.94
Change
-$0.34 (-1.09%)
Net Assets
19.4M

GDOC stock forecast, quote, news & analysis

The investment seeks long-term growth of capital... Show more

Category: #Health
GDOC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for GDOC with price predictions
Jul 18, 2025

GDOC in upward trend: price may jump up because it broke its lower Bollinger Band on July 15, 2025

GDOC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 34 cases where GDOC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Aroon Indicator entered an Uptrend today. In of 187 cases where GDOC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 15, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on GDOC as a result. In of 66 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for GDOC turned negative on July 11, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 35 similar instances when the indicator turned negative. In of the 35 cases the stock turned lower in the days that followed. This puts the odds of success at .

GDOC moved below its 50-day moving average on July 15, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GDOC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Align Technology (NASDAQ:ALGN), Exact Sciences Corp (NASDAQ:EXAS).

Industry description

The investment seeks long-term growth of capital. The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments in U.S. and non‑U.S. health care companies. The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare. The fund is non-diversified.

Market Cap

The average market capitalization across the Goldman Sachs Future Health Care Eq ETF ETF is 76.84B. The market cap for tickers in the group ranges from 2.04B to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is CGON at 2.04B.

High and low price notable news

The average weekly price growth across all stocks in the Goldman Sachs Future Health Care Eq ETF ETF was 5%. For the same ETF, the average monthly price growth was 23%, and the average quarterly price growth was 23%. MLTX experienced the highest price growth at 8%, while NTRA experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Goldman Sachs Future Health Care Eq ETF ETF was 22%. For the same stocks of the ETF, the average monthly volume growth was 10% and the average quarterly volume growth was 7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 73
Price Growth Rating: 54
SMR Rating: 62
Profit Risk Rating: 72
Seasonality Score: 11 (-100 ... +100)
View a ticker or compare two or three
GDOC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
Goldman Sachs ETF Trust200 West StreetNew York
Phone
N/A
Web
N/A